This activity has expired. Credit is no longer available.
This activity was supported by educational grants from Celgene Corporation and Coherus Biosciences, Inc.
New Drug Updates: Hematologic Malignancies
Lauren Held, PharmD, BCOP
Seattle Cancer Care Alliance
Get updated on the FDA-approved therapies for initial or expanded indications for hematologic malignancies across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management.
|
|
These activities, certified for CME/CE/CPE credit, are jointly provided by
  |
in collaboration with
  |